模仿DPD缺陷的trifluridine和tipiracil诱导的DPD抑制:一个病例报告
Antonin Schmitt1, Baptiste Bouillet2, Bernard Royer3,4
1Université Bourgogne Europe, Centre Georges-François Leclerc, Service Pharmacie, INSERM, CTM UMR 1231, TIRECS, Dijon, France.
Frontiers in oncology
|August 28, 2025
概括
在转移性结肠直肠癌 (mCRC) 患者中,用trifluridine/ tipiracil治疗可能导致错误的 uracil水平升高,影响二胺脱酶 (DPD) 测试. 在三里丁/ 蒂皮拉西尔治疗期间,应仔细定时DPD表型,以确保准确的结果.
科学领域:
- 癌症学
- 药理学
- 临床化学
背景情况:
- 像5-甲 (5-FU) 这样的甲胺是转移性结直肠癌 (mCRC) 的标准.
- 三氨酸/ 提皮拉西尔 (TAS-102) 是一种口服药物,越来越多地用于mCRC,包括潜在的第一线治疗.
- 准确的二胺脱酶 (DPD) 活性评估对于安全的胺剂量至关重要.
相关概念视频
Parkinson's Disease: Treatment
376
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
376
Drugs for Treatment of Diarrhea-Predominant IBS
292
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
292


